Stock Scorer

Universal Health Services Inc (UHS)

Universal Health Services Inc reported revenue of 4.6B USD for the quarter ending 30 June 2026, up 8.3% from 4.3B a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 4.6B +8.3%
Operating Income Q2 '26 · ending 30 June 2026 516.7M +3.3%
Net Income Q2 '26 · ending 30 June 2026 358.4M +1.5%
Operating Cash Flow Q2 '26 · ending 30 June 2026 443.3M -19.2%
Free Cash Flow Q2 '26 · ending 30 June 2026 215.7M -23.8%
Shares Outstanding Q2 '26 · ending 30 June 2026 59.9M -9.3%
EPS Q2 '26 · ending 30 June 2026 24.52 +29.3%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 17.4B2B1.5B849.2M
20242024-12-31 15.8B1.7B1.1B1.1B
20232023-12-31 14.3B1.2B717.8M524.7M
20222022-12-31 13.4B1B675.6M262M
20212021-12-31 12.6B1.4B991.6M28M
20202020-12-31 11.6B1.4B944M1.6B
20192019-12-31 11.4B1.2B814.9M804.4M
20182018-12-31 10.8B1.2B779.7M609.8M
20172017-12-31 10.4B1.3B752.3M690.1M
20162016-12-31 9.8B1.3B702.4M813.9M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-304.6B
Q1 '262026-03-314.5B
Q4 '252025-12-314.5B
Q3 '252025-09-304.5B
Q2 '252025-06-304.3B
Q1 '252025-03-314.1B
Q4 '242024-12-314.1B
Q3 '242024-09-304B
Q2 '242024-06-303.9B
Q1 '242024-03-313.8B
Q4 '232023-12-313.7B
Q3 '232023-09-303.6B
Q2 '232023-06-303.5B
Q1 '232023-03-313.5B
Q4 '222022-12-313.4B
Q3 '222022-09-303.3B
Q2 '222022-06-303.3B
Q1 '222022-03-313.3B
Q4 '212021-12-313.3B
Q3 '212021-09-303.2B

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30516.7M
Q1 '262026-03-31502.9M
Q4 '252025-12-31517.2M
Q3 '252025-09-30521.7M
Q2 '252025-06-30500.3M
Q1 '252025-03-31454.8M
Q4 '242024-12-31472.5M
Q3 '242024-09-30384.2M
Q2 '242024-06-30436.4M
Q1 '242024-03-31388.8M
Q4 '232023-12-31331.2M
Q3 '232023-09-30285.4M
Q2 '232023-06-30280.1M
Q1 '232023-03-31278.7M
Q4 '222022-12-31261.4M
Q3 '222022-09-30275.9M
Q2 '222022-06-30233.4M
Q1 '222022-03-31232.9M
Q4 '212021-12-31313.6M
Q3 '212021-09-30314.8M

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30358.4M
Q1 '262026-03-31348.7M
Q4 '252025-12-31445.9M
Q3 '252025-09-30373M
Q2 '252025-06-30353.2M
Q1 '252025-03-31316.7M
Q4 '242024-12-31332.4M
Q3 '242024-09-30258.7M
Q2 '242024-06-30289.2M
Q1 '242024-03-31261.8M
Q4 '232023-12-31216.4M
Q3 '232023-09-30167M
Q2 '232023-06-30171.3M
Q1 '232023-03-31163.1M
Q4 '222022-12-31174.8M
Q3 '222022-09-30182.8M
Q2 '222022-06-30164.1M
Q1 '222022-03-31153.9M
Q4 '212021-12-31239.1M
Q3 '212021-09-30218.4M

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30443.3M
Q1 '262026-03-31401.6M
Q4 '252025-12-31574.7M
Q3 '252025-09-30380.7M
Q2 '252025-06-30549M
Q1 '252025-03-31360M
Q4 '242024-12-31658.4M
Q3 '242024-09-30333M
Q2 '242024-06-30679.3M
Q1 '242024-03-31396.4M
Q4 '232023-12-31452.4M
Q3 '232023-09-30161.7M
Q2 '232023-06-30362.9M
Q1 '232023-03-31290.8M
Q4 '222022-12-31297.3M
Q3 '222022-09-30220.7M
Q2 '222022-06-3032.6M
Q1 '222022-03-31445.4M
Q4 '212021-12-31322M
Q3 '212021-09-30442.2M

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30215.7M
Q1 '262026-03-31184.5M
Q4 '252025-12-31293.5M
Q3 '252025-09-30151.8M
Q2 '252025-06-30283M
Q1 '252025-03-31121M
Q4 '242024-12-31412.5M
Q3 '242024-09-3085M
Q2 '242024-06-30437.9M
Q1 '242024-03-31187.9M
Q4 '232023-12-31246M
Q3 '232023-09-30-38.3M
Q2 '232023-06-30195M
Q1 '232023-03-31122M
Q4 '222022-12-31132.9M
Q3 '222022-09-3059.1M
Q2 '222022-06-30-175.3M
Q1 '222022-03-31245.4M
Q4 '212021-12-31132.4M
Q3 '212021-09-30258.4M

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3059.9M
Q1 '262026-03-3161.7M
Q3 '252025-09-3063.7M
Q2 '252025-06-3065M
Q1 '252025-03-3166M
Q3 '242024-09-3068.1M
Q2 '242024-06-3067.9M
Q1 '242024-03-3168.5M
Q3 '232023-09-3069.6M
Q2 '232023-06-3070.8M
Q1 '232023-03-3171.5M
Q3 '222022-09-3073.1M
Q2 '222022-06-3074.4M
Q1 '222022-03-3176M
Q3 '212021-09-3083.7M
Q2 '212021-06-3085.6M
Q1 '212021-03-3185.8M
Q3 '202020-09-3085.2M
Q2 '202020-06-3085.1M
Q1 '202020-03-3186.5M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-3024.52
Q1 '262026-03-3123.97
Q4 '252025-12-3123.12
Q3 '252025-09-3021.03
Q2 '252025-06-3018.97
Q1 '252025-03-3117.80
Q4 '242024-12-3116.82
Q3 '242024-09-3015.02
Q2 '242024-06-3013.62
Q1 '242024-03-3111.78
Q4 '232023-12-3110.24
Q3 '232023-09-309.53
Q2 '232023-06-309.63
Q1 '232023-03-319.41
Q4 '222022-12-319.15
Q3 '222022-09-309.71
Q2 '222022-06-309.81
Q1 '222022-03-3111.40
Q4 '212021-12-3111.81
Q3 '212021-09-3012.42